Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 66, 165-176
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (15K18800)
- Swedish Research Council ((#20725, #07879)
- Swedish Cancer Foundation ((#213/692)
- MRC (G0801296)
This publication has 69 references indexed in Scilit:
- Novel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptorScientific Reports, 2013
- Interleukin-1R3 mediates interleukin-1–induced potassium current increase through fast activation of Akt kinaseProceedings of the National Academy of Sciences, 2012
- TAK1 in brain endothelial cells mediates fever and lethargyJournal of Experimental Medicine, 2011
- Trpv1Reporter Mice Reveal Highly Restricted Brain Distribution and Functional Expression in Arteriolar Smooth Muscle CellsThe Journal of Neuroscience, 2011
- Nociceptors Are Interleukin-1β SensorsThe Journal of Neuroscience, 2008
- Endothelial-Specific Knockdown of Interleukin-1 (IL-1) Type 1 Receptor Differentially Alters CNS Responses to IL-1 Depending on Its Route of AdministrationThe Journal of Neuroscience, 2007
- Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brainAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient miceBrain, Behavior, and Immunity, 2005
- Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid SecretionJournal of Experimental Medicine, 1998
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990